Sana Biotechnology, Inc. — Director's Dealing 2021

Feb 4, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Sana Biotechnology, Inc. (SANA)
CIK: 0001770121
Period of Report: 2021-02-03

Reporting Person: AGARWAL SUNIL (See Remarks)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1610000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$1.44	2029-07-14	Common Stock (75000)		Direct
Stock Option (Right to Buy)	$1.48	2030-01-26	Common Stock (125000)		Direct

Footnotes

F1: The option vests and becomes exercisable as to 1/48th of the underlying shares in equal monthly installments with the first of such installment on August 15, 2019.

F2: The option vests and becomes exercisable as to 25% of the underlying shares on February 14, 2021 and in 36 equal monthly installments thereafter.